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Tyrosine kinasels are diffusible phosphoinositide metabolites reported to modulate actin
dynamics and tumour cell spreading. In particular, the membrane permeant glycerophosphoinositol 4-
phosphate (GroPIns4P) has been shown to act at the level of the small GTPase Rac1, to induce the rapid
formation of membrane rufﬂes. Here, we have investigated the signalling cascade involved in this process,
and show that it is initiated by the activation of Src kinase. In NIH3T3 cells, exogenous addition of GroPIns4P
induces activation and translocation of Rac1 and its exchange factor TIAM1 to the plasma membrane; in
addition, in in-vitro assays, GroPIns4P favours the formation of a protein complex that includes Rac1 and
TIAM1. Neither of these processes involves direct actions of GroPIns4P on these proteins. Thus, through the
use of speciﬁc inhibitors of tyrosine kinases and phospholipase C (and by direct evaluation of kinase activities
and inositol 1,4,5-trisphosphate production), we show that GroPIns4P activates Src, and as a consequence,
phospholipase Cγ and Ca2+/calmodulin kinase II, the last of which directly phosphorylates TIAM1 and leads
to TIAM1/Rac1-dependent rufﬂe formation.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionAlthough the membrane phosphoinositides represent a minor, but
essential, fraction of the total membrane phospholipids, they have
crucial regulatory roles as docking molecules for protein-and lipid-
binding domains [1–3] and as precursors of signalling molecules [4,5].
They are thus the substrates of different cellular enzymes, including
lipid kinases, phosphatases and phospholipases, which catalyze the
formation of active metabolites that are involved in the regulation of
different cellular functions [6,7].
We have previously investigated the metabolism and physiological
functions of a speciﬁc class of the phosphoinositide metabolites, the
glycerophosphoinositols [7,8]. These are water-soluble products of
phospholipase A2 (PLA2) and lysolipase activities that were originally
identiﬁed in Ras-transformed epithelial cells [9], and were then
characterized in a number of normal and transformed cell systems
[7,10,11]. Recently, we have shown that in thyroid epithelial cells, the
glycerophosphoinositols are speciﬁcally produced by a single enzyme, the
PLA2 IVα isoform, which possesses both PLA2 and lysolipase activities [8].
In these cells, this pathway, and more speciﬁcally the formation of
glycerophosphoinositol (GroPIns), is involved in the control of thyro-+39 0872 570412.
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l rights reserved.tropin-independent cell proliferation [8]. In ﬁbroblasts, glyceropho-
sphoinositol 4-phosphate (GroPIns4P) has a role in promoting actin
cytoskeleton reorganization, through the activation of the small GTPases
of the Rho family [12]. Thus, in serum-starved Swiss 3T3 cells,
exogenously added GroPIns4P stimulates the rapid formation of
membrane rufﬂes, followed at later times by the formation of stress
ﬁbres [12]. This GroPIns4P effect in intact cells involves the activation of
Rac1, as determined by an increased fraction of GTP-bound Rac1 and by a
rapid translocation of green-ﬂuorescent-protein (GFP)-tagged Rac1 into
rufﬂes [12]. No information is available, however, on the mechanism by
which GroPIns4P activates Rac1.
In addition to the effects reported above, GroPIns4P is involved in
other processes in which cytoskeletal rearrangements are also
essential, such as T-cell chemotaxis [13]. Through its ability to inhibit
adenylyl cyclase activity [14], GroPIns4P enhances chemokine-
induced chemotactic responses in Jurkat T-cells and in peripheral
blood lymphocytes [13]. This GroPIns4P activity is due to the
activation of the Rac1 guanine-nucleotide-exchange factor (GEF)
Vav, which in turn regulates actin polymerization in these systems
[13,15]. Moreover, when exogenously added to breast carcinoma and
melanoma cell cultures, both GroPIns and GroPIns4P decrease the
ability of these cells to degrade, and thus invade, the extracellular
matrix, indicating the potential of these compounds in the control of
tumour spreading [16].
Following on from the above, the present study was under-
taken to deﬁne the molecular pathways involved in GroPIns4P-
dependent rufﬂe formation in ﬁbroblasts. This is relevant to the
general remodelling of actin-based structures that are involved in
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that are controlled by a number of signalling molecules and
protein cofactors, including lipid kinases, serine/threonine and
tyrosine kinases [19–22], phospholipases [23,24], scaffold proteins
(such as IRSp53, ﬁlamin and Abl) [25–27], WASP family proteins
[28] and the GTPases of the Rho family [29,30]. In addition, lipids,
and more speciﬁcally the membrane phosphoinositides phospha-
tidylinositol 4,5-bisphosphate (PtdIns4,5P2) and phosphatidylinosi-
tol 3,4,5-trisphosphate (PtdIns3,4,5P3), have been shown to be
relevant for actin cytoskeleton organization in three speciﬁc ways:
(i) direct regulation of the activities and targeting of actin
regulatory proteins, such as exchange factors, WASP family
proteins and proﬁlin [31–33]; (ii) stimulation of actin nucleation
and the subsequent actin polymerization through the dissociation
of capping proteins, such as CapZ and gelsolin, from the actin
ﬁlaments [34]; and (iii) formation of cytoskeleton-plasma-mem-
brane connections to form stable, bundled actin ﬁbres [35,36].
Using biochemical and morphological approaches, we now show
that GroPIns4P activates Src kinase, and thus initiates a phosphoryla-
tion cascade that leads to the activation of the speciﬁc GEF of Rac1, T-
cell lymphoma invasion and metastasis protein-1 (TIAM1). This
pathway is responsible for Rac1 activation, and ﬁnally for the
formation of the membrane rufﬂes induced by GroPIns4P.
2. Materials and methods
2.1. Reagents
NIH3T3, HEK293T and SYF cells were from the American Type
Culture Collection (ATCC, USA). Dulbecco's Modiﬁed Eagle's Medium
(DMEM), OptiMEM, calf serum (CS), penicillin, streptomycin, trypsin-
EDTA, L-glutamine and the Lipofectamine/plus reagent were from
Gibco BRL (Grand Island, NY, USA). Foetal calf serum (FCS) was from
Biochrom KG (Berlin, Germany). The TIAM1- and wild-type-Src-
expressing constructs (see below) were kindly provided by I. Fleming
(University of Dundee, Scotland, UK) and S. Gutkind (NIH, Bethesda,
USA), respectively. The pEGFP-Rac1 was from our laboratory [12],
while pEGFP was from Molecular Probes (Eugene, OR, USA). The
constructs expressing the myc-tagged constitutively active forms of
Rac1 (myc-L61Rac1), RhoA (myc-L63RhoA) and Cdc42 (myc-
L61Cdc42) were kindly provided by A. Hall (Sloan-Kettering Institute
for Cancer Research, NY, USA). TRITC- and FITC-labelled phalloidin
were from Sigma-Aldrich (St. Louis, MO, USA), and Fluo3-AM and the
Alexa 488-and Alexa 546-conjugated goat anti-rabbit and anti-mouse
antibodies from Molecular Probes. For the antibodies: anti-HA was
from Babco (Richmond, CA, USA), anti-p-Src (phosphorylated on
tyrosine 416, p-Tyr416) from Upstate (Chicago, IL, USA), anti-PLCβ1,
anti-PLCγ1, anti-TIAM1 (C-16), anti-c-Src were from Santa Cruz (Santa
Cruz, CA, USA), the polyclonal anti-TIAM1 antibody was kindly
provided by J.G. Collard (The Netherlands Cancer Institute), mono-
clonal anti-c-myc Cy3 conjugate clone 9E10 from Sigma-Aldrich and
monoclonal antiphosphotyrosine clone 4G10 from Upstate. GroPIns4P
was prepared by deacylation of phosphatidylinositol 4-phosphate
(Avanti Polar Lipids, Alabaster, AL, USA), following [37]. KN-93,
U73122, U73433, PP2, SU6656, GroPIns, mowiol and the secondary
antibodies conjugated to horse-radish peroxidase and directed against
mouse and rabbit IgGs were from Calbiochem (La Jolla, CA, USA).
Ionomycin, ATP, genistein and 1,2-bis-(o-aminophenoxy)-ethane-N,
N,-N',N'-tetraacetic acid tetraacetoxy-methyl ester (BAPTA-AM) were
from Sigma-Aldrich. PDGF, CaMKII, Src, the “CaMKII activity assay” kit
and the “Src assay kit” were from Upstate. The “D-myo-inositol 1,4,5-
trisphosphate [3H]-Biotrak assay system” and the ECL reagents were
from Amersham Pharmacia (Piscataway, NJ, USA). [γ32P]-ATP (3,000
Ci/mmole), Filter Count and Ultima Gold scintillation ﬂuids were from
Perkin Elmer Life Sciences (Boston, MA, USA). All other reagents were
of the highest purities from standard commercial sources.2.2. Cell culture, transfection and treatments
Cells were grown in DMEM supplemented with 2 mM glutamine,
100 U/ml penicillin, 0.1 mg/ml streptomycin, 10% CS (mouse
ﬁbroblasts, NIH3T3 cells) or FCS (human cell lines, HEK293T cells,
mouse embryo ﬁbroblasts, SYF cells). For immunoﬂuorescence
experiments, cells were seeded onto glass coverslips in 24-well plates
at a concentration suitable for 70% conﬂuence without transfection or
50% conﬂuence in the case of Lipofectamine-based cell transfection. In
the latter, about 24 h after seeding, NIH3T3 and SYF cells were
transiently transfected with different plasmids (pEGFP-Rac1 encoding
Rac1-GFP; pcDNA-C1199-TIAM1 encoding TIAM1-HA, pEGFP-C1199-
TIAM1 encoding TIAM1-GFP, pRK5-L61Rac1 encoding myc-L61Rac1,
pRK5-L63RhoA encoding myc-L63RhoA, pRK5-L61Cdc42 encoding
myc-L61Cdc42 and pSM-c-Src encoding c-Src) with the Lipofecta-
mine/plus reagent, following the manufacturer instructions. Before
treatments, NIH3T3 and SYF cells were serum starved in DMEM with
2 mM glutamine, 1 U/ml penicillin and streptomycin for 24 h and with
0.1% FCS for 12 h, respectively. Then the cells were treated with the
different stimuli and/or inhibitors, as indicated in the text and/or
Figure legends.
2.3. Immunoﬂuorescence analysis for membrane rufﬂing and protein
localization
For rufﬂe assessment after treatments, the cells (NIH3T3 or SYF)
were ﬁxed with 4% (w/v) paraformaldehyde in PBS for 12 min,
permeabilised in blocking solution (0.05% saponin, 0.5% BSA, 50 mM
NH4Cl, in PBS) for 20 min, and then incubated with 0.1 μg/ml TRITC-
or FITC-labelled phalloidin for 45 min for ﬁlamentous actin visualiza-
tion [12]. The samples (independent experiments in duplicate; 200
cells per sample) underwent blinded morphological scoring for rufﬂe
formation, under an Axiophot microscope using a 100×1.3 objective
(Carl Zeiss, Jena, Germany), as: absence, 0; partial response, 1; full
response, 2 (see also [12]). This provided a maximum score of 400,
with the data given as percentages of each response with respect to
the respective control.
For protein localization, the effects of different agents were also
analysed in NIH3T3 and SYF cells: the cells were ﬁxed and
permeabilized with blocking solution (see above), and then incubated
with the speciﬁed primary and ﬂuorescent-probe-(Alexa 488 or Alexa
546)-conjugated secondary antibody diluted in blocking solution and
stained for actin (see above and [12]). To determine the speciﬁcity of
GFP-tagged constructs, the same experiments were also performed
with cells overexpressing GFP. This always showed a nuclear and
cytoplasmic localization for GFP that did not change upon treatment.
The samples were then analyzed with blinded quantiﬁcation under an
LSM 510 confocal microscope equipped with a 63× objective (Zeiss,
Germany). Optical confocal sections were taken at 1 Airy unit with a
resolution of 512×512 pixels and exported as TIFF ﬁles. The
quantitative evaluation of the immuno-staining patterns was per-
formed on at least 50 cells per sample, in at least three independent
experiments, each in duplicate. The data are expressed as percentages
of cells displaying a given pattern.
The endogenously expressed TIAM1 was also followed in NIH3T3
cells using a polyclonal anti-TIAM1 antibody kindly received from J.G.
Collard (The Netherlands Cancer Institute) (see Results), however the
high level of background labelling prevented a good resolution of the
speciﬁc signal.
2.4. GroPIns4P-induced translocation of Rac1 and TIAM1, and Vav1
activation
For the membrane translocation of Rac1 and TIAM1, NIH3T3 cells
were serum starved in DMEMwith 2 mM glutamine, 1 U/ml penicillin
and 0.1 mg/ml streptomycin for 24 h, stimulated, lysed and processed
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as previously reported [13].
2.5. TIAM1-HA pull-down assay
Cell lysates (30 μg/μl) were prepared from HEK293T cells over-
expressing TIAM1-HA [39]. The cells were lysed in 25 mM Tris–HCl,
pH 7.6, 100 mM NaCl, 10 mM MgCl2, 1% glycerol and 1% NP-40, and
then centrifuged at 90,000 ×g for 30 min at 4 °C. Ten microliters of the
supernatant were diluted (1:15) in reaction buffer (25 mM Tris-HCl,
pH 7.6,100mMNaCl, 10mMMgCl2), and cleared with 50% glutathione
resin for 1 h at 4 °C on a rotating wheel, and then incubated for 10 min
at 37 °C with 50 μM GroPIns4P. Finally, 4 μg puriﬁed Rac1-GST or
puriﬁed GST [12], 10 μl 50% glutathione resin and 20 μl 2 mg/ml BSA
(ﬁnal volume 200 μl) were added, and the samples were incubated for
1 h at 4 °C on a rotating wheel. The pellets were recovered by
centrifugation at 800 ×g for 6 min at 4 °C, and after 3 washes with
reaction buffer they were analyzed by immuno-blotting with the anti-
TIAM1 antibody. The amount of TIAM1-HA co-immunoprecipitated
with Rac1-GST was quantiﬁed by the NIH imaging programme
(densitometric analysis).Fig. 1. GroPIns4P-dependent rufﬂe formation and Rac1 translocation to the plasma membran
the indicated times. Fixed cells were stained with FITC-labelled phalloidin and analyzed by c
methods and [12]. Data are expressed as percentages of the unstimulated control for each
Representative confocal images of actin staining, as indicated. Scale bars: 10 μm. (C) Rep
membrane fractions. MW, molecular-weight markers (kDa). (D) Quantiﬁcation of Rac1-GFP
indicated. The quantitative evaluation of the immuno-staining patterns was performed on at
of total cells showing plasma-membrane localization of Rac1-GFP, as means (±s.d.) of at lea
⁎⁎Pb0.01, ⁎⁎⁎Pb0.001, compared to untreated sample (paired Student's t test).2.6. CaMKII activity assay
NIH3T3 cells were plated at 3.5×105 cells/well in 6-well plates, and
the day after they were starved in DMEM, 0.1% BSA. After 20 h
starvation, the cells were stimulated with 50 μM GroPIns4P or 10 ng/
ml PDGF. After treatments, the cells were harvested, lysed with 30
passes through a 27-gauge needle in 20 mMMOPS, pH 7.5, 25 mM β-
glycerophosphate, 1 mM Na3VO4, 1 mM DTT with protease inhibitors
(0.5 μg/ml leupeptin, 2 μg/ml aprotinin, 0.5 mM phenanthroline, 2 μM
pepstatin and 1 mM PMSF), and centrifuged at 2,000 ×g for 3 min at
4 °C. The CaMKII enzymatic activity was measured with the “CaMKII
activity assay” kit (Upstate) [40], either in the absence (ﬁnal 5 mM
EGTA) or presence (ﬁnal 2 mM CaCl2) of Ca2+. The same assay was also
performed using puriﬁed CaMKII. Here, 0.25 μg puriﬁed CaMKII was
incubated with 50 μM GroPIns4P, and then the CaMKII activity was
carried out following the same procedure described above.
2.7. [Ca2+]i measurements
NIH3T3 cells were loaded with 4 μM Fluo3-acetoxymethyl ester
(Fluo3-AM) in HEPES-buffered saline solution (10 mM HEPES, pH 7.0,e. Serum-starved NIH3T3 cells were treated with 50 μMGroPIns4P or 10 ng/ml PDGF for
onfocal microscopy. (A) Quantiﬁcation of rufﬂe formation, as indicated in Materials and
time point, as means (±s.d.) of three independent experiments, each in duplicate. (B)
resentative Western blot showing endogenous Rac1 localization in the cytosolic and
translocation to the plasma membrane in cells overexpressing Rac1-GFP and treated as
least 50 cells per sample (seeMaterials andmethods). Data are expressed as percentages
st three independent experiments, each in duplicate. Statistical signiﬁcance: ⁎Pb0.05,
2314 B.M. Filippi et al. / Biochimica et Biophysica Acta 1783 (2008) 2311–2322137 mM NaCl, 5 mM KCl, 4 mM MgCl2, 3 mM CaCl2 and 25 mM
glucose) for 30 min at 37 °C, as previously described [41]. The
ﬂuorescence measurements were carried out in the HEPES-buffered
saline solution under an IX70 microscope (Olympus, Hamburg,
Germany) equipped with a TILL Photonics imaging system (Gräfelﬁng,
Germany). The cells were scanned for at least 30 s to establish base-
line ﬂuorescence and to check for spontaneous [Ca2+]i rises, then
movies were taken over 8 min following the addition of 50 μM
GroPIns4P and the other stimuli (see text and Fig. 6). The various
inhibitors were applied before the stimulation.
Image analysis: Cells were selected at random and the ﬂuorescence
of each frame was calculated by the TILL Photonics imaging system.
After background subtraction, ﬂuorescence values were plotted as
increases in ﬂuorescence per second. The estimation of Fluo3-AMFig. 2. GroPIns4P-dependent translocation of TIAM1 and Rac1 to the plasma membrane. Seru
or TIAM1-HA and Rac1-GFP (D) were treated with 50 μM GroPIns4P or 10 ng/ml PDGF f
localization in the membrane fractions. MW, molecular-weight marker (kDa). For the panels
phalloidin (B and C) or the anti-HA antibody (D), and analyzed by confocal microscopy. (B
evaluation of the immuno-staining patterns was performed on at least 50 cells per sample
membrane localization of TIAM1-GFP, as means (±s.d.) of four independent experiments, eac
actin staining (red), as indicated. Scale bars, 5 μm. (D) Representative confocal images of Rac1
signiﬁcance: ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.001, compared to untreated sample (paired Studenﬂuorescence intensity (representative of [Ca2+]i) was reported as the
pseudo-ratio (ΔF/F0) (see Table 2 and references herein).
2.8. InsP3 measurements
NIH3T3 cells were plated at 3.5×105 cell/well in 6-well plates, and
the day after they were serum starved. After 20 h of starvation, the
cells were stimulated in DMEM plus 20 μM LiCl at 37 °C for 2 min to
15 min with 50 μM GroPIns4P, 5 I.U./ml thrombin, 10 ng/ml PDGF or
100 μM ATP. For the experiments performed with cell homogenates,
the NIH3T3 cells were harvested and lysed by 30 passes through a 27-
gauge needle, in a buffer containing 20 mM HEPES, pH 7.4, 3 mM
EGTA, 0.2 mM EDTA, 0.83 mM MgCl2, 1.5 mM CaCl2, 20 mM NaCl,
30 mMKCl, 1 mMDTT, 20 mM LiCl and protease inhibitors. Then thesem-starved NIH3T3 cells not transfected (A), overexpressing TIAM1-GFP alone (B and C)
or the indicated times. (A) Representative Western blot showing endogenous TIAM1
reporting immunoﬂuorescence data (B-D), ﬁxed cells were stained with TRITC-labelled
) Quantiﬁcation of TIAM1-GFP localization at the plasma membrane. The quantitative
(see Materials and methods). Data are expressed as percentages of cells with plasma-
h in duplicate. (C) Representative confocal images of TIAM1-GFP localization (green) and
-GFP (green) and TIAM1-HA (red) localization, as indicated. Scale bars: 5 μm. Statistical
t's t test).
Fig. 3. Rac1-GST pull-down assay from lysates of TIAM1-overexpressing cells. Lysates
from HEK293T cells overexpressing TIAM1-HA (120 μg) were diluted, pre-cleared and
incubated with 50 μM GroPIns4P for 10 min at 37 °C (see Materials and methods).
Finally, 4 μg puriﬁed Rac1-GST or GST alone, 10 μl glutathione resin and 200 μg/ml BSA
were added, and the samples incubated for 1 h at 4 °C on a rotating wheel. Bound
proteins were separated by centrifugation, as reported in the Materials and methods. A
fraction of the supernatant (Unbound, panel A on the left) and the resins with the bound
proteins (Pull-down, panel A on the right) were recovered and analysed by SDS-PAGE
and Western blotting. The ﬁgure shows the Ponceau staining of the blots as loading
control and the immuno-blotting with the anti-TIAM1 antibody (see Materials and
methods). MW, molecular-weight markers (kDa). (B) Quantiﬁcation of TIAM1 co-
precipitated with Rac1-GST by densitometric analysis with the NIH Image programme.
Data are expressed as percentages of unstimulated control, as means (±s.d.) of four
independent experiments, each in duplicate. Statistical signiﬁcance: ⁎⁎Pb0.01,
compared to untreated sample (paired Student's t test).
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incubations with the indicated compounds were stopped by addition
of 20% perchloric acid, and the InsP3 levels were determined using the
“D-myo-inositol 1,4,5-trisphosphate [3H] - Biotrak assay system” (Amer-
sham Pharmacia). With the cell homogenates, the anti-PLCβ and anti-
PLCγ antibodies (20 μg/ml) [42] were added prior to stimulation.
2.9. Src activation assay
NIH3T3 cells were plated into 6-well dishes (3.5×105 cells/well).
The day after, the cells were serum starved for 20 h and then
stimulated with 50 μM GroPIns4P and 10 ng/ml PDGF. After this
treatment, the cells were lysed in buffer containing 60 mM Tris–HCl,
pH 7.4, 30 μM β-glycerophosphate, 50 μM β-mercaptoethanol, 1 mM
Na3VO4, 2% SDS, 10% glycerol and protease inhibitors (as above) and
processed for SDS-PAGE and Western blotting with anti-p-Src (p-
Tyr416) and anti-c-Src antibodies. The extent of Src phosphorylation
was evaluated using an NIH imaging system and normalised for the
amounts of total Src. Across the repeated independent experiments,
data are given as percentages of each response with respect to the
relevant control. The assay with the puriﬁed Src was performed with
NIH3T3 cells lysed with 30 passes through a 27-gauge needle in a
buffer containing 60 mM Tris–HCl, pH 7.4, 30 μM β-glycerophosphate,
50 μM β-mercaptoethanol, 1 mM Na3VO4, 2% SDS, 10% glycerol and
protease inhibitors, followed by centrifugation at 2000 ×g for 3 min at
4 °C. Thus, 0.25 μg puriﬁed Src was incubated with 50 μMGroPIns4P in
the absence and presence of 200 μg NIH3T3 cell lysate, with Src
activationmeasured using the commercial “Src assay kit” kit (Upstate).
2.10. Statistical analysis
All experiments are presented as means of duplicate or triplicate
determinations, which were repeated at least three times. Statistical
analysis was carried out using the paired Student's t test.
3. Results
3.1. GroPIns4P triggers rufﬂe formation and Rac1 translocation to the
plasma membrane in NIH3T3 cells
In NIH3T3 cells, the addition of GroPIns4P (at 50 μM, unless
otherwise speciﬁed) induced a rapid increase in rufﬂe formation, to a
level 2.5-fold the control (within 2 min), which decreased to some
140% of control after 5 min, as detected by immunoﬂuorescence
analyses (Fig. 1A, B and Materials and methods). This effect of
GroPIns4P was dose dependent, from around 10% stimulation at 1 μM
to a maximal response at 50 μM, as has also been seen in Swiss 3T3
ﬁbroblasts [12]. Longer times of exposure to GroPIns4P (15–20 min)
led to the formation of stress ﬁbres in both of these cell systems
(Beatrice Maria Filippi, unpublished data) [12]; whereas a 5 min
treatment with PDGF (10 ng/ml; used as a positive control in all
experiments) produced an increase in rufﬂes to a level 3.8-fold the
control, with the appearance of circular dorsal waves (circular rufﬂes)
[43] (Fig. 1A and B).
Western blotting revealed that the GroPIns4P-induced formation of
membrane rufﬂes was associated with the activation (evaluated by
afﬁnity precipitation of GTP-bound Rac1, data not shown and [12]) and
translocation of endogenous Rac1 from the cytosolic fraction to the
membrane fraction (Fig. 1C). This was conﬁrmed by following the
translocation of overexpressed Rac1-GFP to the plasma membrane by
immunoﬂuorescence (Fig. 1D; Supplementary Information, Figure S1 and
S2). This translocation occurred in 75% of the stimulated cells (which
represented a level 2.3-fold the control, as revealed by blinded scoring;
Fig. 1D and Materials and methods).
As a control, the constitutively active forms of Rac1 (L61Rac1),
RhoA (L63RhoA) and Cdc42 (L61Cdc42) were overexpressed inNIH3T3 cells and the rearrangements of the actin cytoskeleton were
monitored (see Materials and methods and Supplementary Informa-
tion, Figure S3). The rufﬂes (and stress ﬁbres) formed under these
conditions were reminiscent of those present in GroPIns4P-stimulated
cells, whereas no ﬁlopodiawere observed upon GroPIns4P stimulation
(Fig. 1B and Supplementary Information, Figure S3).
3.2. GroPIns4P-dependent Rac1 activation and rufﬂe formation requires
TIAM1
To determine themolecularmechanisms of this GroPIns4P-dependent
Rac1 activation and translocation to the plasmamembrane, we looked for
the speciﬁc GEF involved in this process. In Jurkat T-cells GroPIns4P
induces Rac1 stimulation by increasing the phosphorylation level and
activation of the exchange factor Vav [13]; in contrast, in NIH3T3 cells
treated with GroPIns4P, no modiﬁcation of Vav1 phosphorylation was
detected (data not shown). The possibility that GroPIns4P could activate
Vav3 (known to be expressed at low levels in NIH3T3 cells, [44,45]) was
also excluded based on the observation that this GEF acts also on Cdc42,
inducing ﬁlopodia formation, an effect never detected upon GroPIns4P
addition [12].
Among the other GEFs that can act on Rac1, we then investigated
TIAM1, since it is expressed in NIH3T3 cells and it is known to be
speciﬁcally involved in Rac1-dependent rufﬂe formation [46]. Western
blotting indicated that in parallel with Rac1, endogenous TIAM1 was also
enriched in the membrane fraction upon GroPIns4P stimulation (Fig. 2A).
As endogenous TIAM1 could not be followed by immunoﬂuorescence of
intact cells due to the lack of suitable antibodies (see Materials and
methods) [47], serum-starved NIH3T3 cells overexpressing TIAM1-GFP
(see Materials and methods) were stimulated with GroPIns4P. Under
these conditions, TIAM1-GFP was seen to translocate to the plasma
membrane in 55% of the cells within 2 min (reaching a level 2.5-fold the
control; Fig. 2B and Materials and methods); this was maintained for up
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addition, TIAM1-GFP co-localized with actin, indicating its association
with membrane rufﬂes (Fig. 2C). By 30 min of GroPIns4P treatment,
TIAM1 was completely redistributed back into the cytosol (Fig. 2B).
To directly evaluate whether this GroPIns4P action is exerted at the
level of the interaction between TIAM1 and Rac1, immunoﬂuorescence
assayswere performed inNIH3T3 cells overexpressing bothRac1-GFPand
TIAM1-HA (see Materials and methods). Within 2 min of GroPIns4P
addition to cells, translocation to the same plasma-membrane structures
of bothRac1-GFPandTIAM1-HAwas seen (Fig. 2D),whichpersisted forup
to 20min (data not shown), in linewith the translocation of the individual
proteins shown above (Figs.1C andD, 2A and B). GroPIns4P also increased
the interaction between TIAM1 and Rac1 to a level 2.8-fold the control
when added to in-vitro pull-down experiments performed with puriﬁed
Rac1-GST and lysates of HEK293T cells overexpressing TIAM1-HA (Fig. 3
and Materials and methods).
These data indicate that GroPIns4P induces the interaction of Rac1
and TIAM1 and their co-localization at the site of membrane rufﬂe
formation at the plasma membrane.
3.3. Ca2+/calmodulin kinase II is involved in GroPIns4P-dependent rufﬂe
formation
The data reported above are consistent with the hypotheses that
GroPIns4P is either acting by directly binding to, and favouring the
formation of, the TIAM1/Rac1 complex, or that as with PDGF, GroPIns4P
acts on one of the signalling enzymes upstream of TIAM1 activation. The
latter possibility was analyzed by investigating the contributions of a
number of known TIAM1 regulators. This initially led to the exclusion of
phosphoinositide 3-kinase, as indicated by using the inhibitor wortman-
nin with GroPIns4P-induced membrane rufﬂes (Beatrice Maria Filippi,
unpublished data and [12]). We then analysed Ca2+/calmodulin kinase II
(CaMKII), which is known to phosphorylate TIAM1 on threonine residues,
thus favouring TIAM1 translocation to the plasma membrane [38,48]. In
serum-starved cells treated with a CaMKII-speciﬁc inhibitor (20 μM KN-
93, which results in a complete inhibition of CaMKII enzymatic activity)
[49,50], the GroPIns4P effect on rufﬂe formation was completely blocked
(Table 1). In parallel, PDGF stimulation of rufﬂe formation underwent a
60% inhibitionwith KN-93, while the phorbol ester phorbol 12-myristate
13-acetate (PMA), which induces rufﬂe formation in a CaMKII-indepen-
dent manner by activating protein kinase C (PKC) [51,52], was not
inhibited by KN-93 (Table 1).Table 1
Rufﬂe formation in NIH3T3 cells
No
pretreatment
Pretreatments (% unstimulated control)















GroPIns4P 247±57⁎⁎ 72±24 13±30⁎ 140±20⁎ 162±22⁎ 200±25⁎⁎
PDGF 378±116⁎⁎ 149±24⁎ 163±42⁎ 220±19⁎⁎ 245±165⁎⁎ 350±3⁎⁎⁎
PMA 193±55⁎⁎ 194±19⁎ nd nd nd nd
Serum-starved NIH3T3 cells were pretreated with 20 μM KN-93 (CaMKII inhibitor; 24 h),
10 μMSU6656 (Src inhibitor; 10min),10 μMPP2 (Src inhibitor; 10min), 5 μMU-73122 (PLC
inhibitor; 10 min) or 5 μM U-73433 (inactive analogue of PLC inhibitor; 10 min), and then
stimulated with 50 μM GroPIns4P (2 min), 10 ng/ml PDGF (5 min) or 10 μM PMA (5 min).
Fixed cells were stained with TRITC-labelled phalloidin and subjected to blinded
morphological scoring for rufﬂe formation (see Materials and methods). Data are given
as percentages of each responsewith respect to their relevant control, asmeans (±s.d.) of at
least three independent experiments, each performed in duplicate. The 100% refers to the
unstimulated sample and represents the amount of cells presenting membrane rufﬂes
under basal conditions. GroPIns4P, glycerophosphoinositol 4-phosphate; PMA, phorbol 12-
myristate 13-acetate.
Statistical signiﬁcance: ⁎P<0.05, ⁎⁎P<0.01, ⁎⁎⁎P<0.001, compared to the respective
untreated sample (paired Student's t test). nd, not determined.
a In parentheses: absolute rufﬂe quantiﬁcation score obtained by counting 200 cells
per sample. Each 100% value of the unstimulated samples refers to its corresponding
score.
Fig. 4. CaMKII activity is necessary for GroPIns4P effects in NIH3T3 cells. Serum-starved
NIH3T3 cells with (A and B) or without (C) overexpression of TIAM1-GFP were
pretreated in the absence (A–C) or presence (A and B) of 20 μMKN-93 (CaMKII inhibitor;
24 h, during serum starvation) and stimulated with 50 μM GroPIns4P or 10 ng/ml PDGF
for the indicated times. (A) Cells were ﬁxed and stained with TRITC-labelled phalloidin
and analyzed by confocal microscopy. Representative confocal images of TIAM1-GFP
localization (green) and actin staining (red), as indicated. Scale bars: 10 μm. (B)
Quantiﬁcation of TIAM1-GFP localization at the plasma membrane, as indicated (see
Materials and methods). Data are expressed as percentages of total cells with plasma-
membrane localization of TIAM1-GFP, as means (±s.d.) of four independent experi-
ments, each in duplicate. (C) Cell homogenates were assayed for CaMKII activation, as
indicated (see Materials and methods). Data are expressed as percentages of maximum
activation when cells were lysed in the presence of 2 mM Ca2+, as means (±s.d.) of three
independent experiments, each in duplicate. Statistical signiﬁcance: ⁎P<0.05, ⁎⁎P<0.01,
⁎⁎⁎P<0.001, compared to untreated sample (paired Student's t test).The CaMKII inhibitor was also used in immunoﬂuorescence
experiments analyzing TIAM1-GFP localization. In line with the data
reported above on rufﬂe formation (Table 1), KN-93 completely
inhibited the effects of both GroPIns4P and PDGF on TIAM1-GFP
Fig. 5. BAPTA-AM block of GroPIns4P-dependent CaMKII activation and TIAM1 translocation to the plasma membrane. Serum-starved NIH3T3 cells without (A) or with (B and C)
overexpression of TIAM1-GFP were pretreated in the absence or presence of 20 μM BAPTA-AM (Ca2+chelator; 30 min, at the end of serum starvation) and stimulated with 50 μM
GroPIns4P for the indicated times. (A) Cells were assayed for CaMKII activation as indicated. Data are expressed as percentages of maximum activation when cells were lysed in the
presence of 2 mM Ca2+, as means (±s.d.) of three independent experiments, each in duplicate. ZT, zero time unstimulated control. (B) Quantiﬁcation of TIAM1-GFP localization at the
plasma membrane, as indicated (see Materials and methods). Data are expressed as percentages of total cells with plasma-membrane localization of TIAM1-GFP, as means (±s.d.) of
two independent experiments, each in duplicate. ZT, zero time unstimulated control. (C) Representative confocal images of TIAM1-GFP localization (green) and actin staining (red), as
indicated. Scale bars: 10 μm. Statistical signiﬁcance: ⁎P<0.05, ⁎⁎P<0.001 compared to the respective ZT samples without BAPTA-AM pretreatment (paired Student's t test).
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consistent with CaMKII being part of the signalling of GroPIns4P-
induced TIAM1 membrane translocation and rufﬂe formation.
Indeed, in intact cells, GroPIns4P activated the CaMKII enzymatic
activity (see Materials and methods) in a rapid (within 1.5 min) and
transient manner, with a maximal 100% increase (over untreated
samples), as also seen for PDGF (Fig. 4C). With GroPIns4P, the CaMKII
activity then returned to basal levels within 2.5 min (Fig. 4C).
However, GroPIns4P did not directly stimulate CaMKII activity, sinceFig. 6. GroPIns4P-induced [Ca2+]i increases in NIH3T3 cells. Cells were loadedwith 4 μMFluo3
increases (see Materials and methods). (A) Selected frames within 100 s (sec) from a repre
(green, low; red, high) after addition of 50 μMGroPIns4P. (B) Quantiﬁcation of the kinetics of
are expressed as ﬂuorescence values calculated by the Till Photonic software (see Materialswhen puriﬁed CaMKII was used in these assays, no effects of
GroPIns4P were detected (the puriﬁed CaMKII basal activity was
4.10 ±0.49 pmol phosphate incorporated into the substrate peptide/
min; see Materials and methods).
GroPIns4P-dependent activation of CaMKII could involve modu-
lation of intracellular calcium concentrations ([Ca2+]i), as Ca2+ is
required together with calmodulin for CaMKII enzymatic activity [53].
CaMKII activity assays were thus performed after chelating [Ca2+]i
with the calcium chelator BAPTA-AM [50]. When NIH3T3 cells were-AM (30min), washed, and then treatedwith 50 μMGroPIns4P andmonitored for [Ca2+]i
sentative time-lapse movie showing the colour-coded intensities representing [Ca2+]i
[Ca2+]i increase stimulated by 50 μMGroPIns4P in the two cells in (A) (Cell 1, Cell 2). Data
and methods; arbitrary units). The arrow indicates the addition of GroPIns4P.
Table 3
InsP3 production in NIH3T3 cells
Pretreatments Treatments (% increase over control)
2 min 5 min 15 min
(a) Intact cellsa
GroPIns4P w/o 22.0±4⁎ 19.0±9⁎ nd
PDGF w/o 37.0±19⁎ 56.0±30⁎ nd
ATP w/o nd 72.5±29⁎⁎ nd
Thrombin w/o nd 99.6±24⁎⁎ nd
(b) Cell homogenatesb
GroPIns4P w/o 0.7±17 28.0±16⁎ 81.0±19⁎
GroPIns4P Anti-PLCγ ab nd nd 13.7±12
GroPIns4P Anti-PLCβ ab nd nd 64.0±33⁎
Thrombin w/o nd 31.0±4⁎ 174.0±53⁎⁎
Thrombin Anti-PLCγ ab nd nd 158.0±32⁎⁎
Thrombin Anti-PLCβ ab nd nd 34.0±3⁎⁎
Intact cells and cell homogenates (400 μg/sample) were treated with 50 μM GroPIns4P,
10 ng/ml PDGF, 100 μM ATP and/or 5 I.U./ml thrombin for the indicated times. The
intracellular InsP3 levels were quantiﬁed using a commercial kit (see Materials and
methods). The data are means (±s.d.) of at least four independent experiments and are
given as percentage increases over basal (untreated sample; as 100%). Where indicated,
the quantiﬁcation of InsP3 production was carried out in the presence of the anti-PLCβ
or anti-PLCγ antibodies (ab) (see Materials and methods). w/o, without.
Statistical signiﬁcance: ⁎Pb0.05, ⁎⁎Pb0.01, compared to the untreated sample (paired
Student's t test). nd, not determined.
a Basal level of InsP3 of 0.45±0.3 pmols/7×105 cells.
b Basal level of InsP3 of 2.23±1.7 pmols/400 μg of homogenate.
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of GroPIns4P did not elicit the expected activation of CaMKII (Fig. 5A).
This indicates that GroPIns4P requires an increase in [Ca2+]i to activate
CaMKII.
In parallel, immunoﬂuorescence experiments in TIAM1-GFP-over-
expressing NIH3T3 cells pretreated with BAPTA-AM and stimulated
with GroPIns4P did not show any translocation of TIAM1-GFP to the
plasma membrane or any rufﬂe formation (Fig. 5B and C).
In summary, [Ca2+]i and CaMKII mediate the activation and
translocation of TIAM1 to the plasma membrane induced by
GroPIns4P.
3.4. GroPIns4P modulates intracellular Ca2+ concentrations through
phospholipase Cγ activation
The requirement for GroPIns4P-dependent increases in [Ca2+]i
prompted us to analyze the mechanisms involved in this process. To
this end, we monitored [Ca2+]i by cell imaging in NIH3T3 cells loaded
with the calcium-probe Fluo3-AM (see Materials and methods). These
cells were then treated with GroPIns4P (from 1 μM to 50 μM), and/or
with the controls of PDGF (10 ng/ml), ATP (100 μM) and ionomycin
(10 μM) (Fig. 6). The [Ca2+]i increases induced by GroPIns4Pwere rapid
(maximal within 25 s) and transient (persisting for up to 50 s) (Fig. 6A
and B). Table 2 provides a summary of the [Ca2+]i levels (see also
Materials and methods) stimulated by GroPIns4P and a range of
further pretreatments in both the absence and the presence of speciﬁc
enzyme inhibitors (see also below). As indicated, GroPIns4P produced
a pronounced increase in Fluo3-AM ﬂuorescence in about 60% of the
cells analyzed per sample, well in linewith the effects of ATP and PDGFTable 2
Quantiﬁcation of [Ca2+]i in NIH3T3 cells
Pretreatments ΔF/F0 % of cells
Control w/o 0.06±0.16 2.5±8
GroPIns4P w/o 1.08±0.14⁎⁎⁎ 58±3
PDGF w/o 0.94±0.08⁎⁎⁎ 65±9
ATP w/o 1.52±0.09⁎⁎⁎ 82±3
Ionomycin w/o 1.33±0.16⁎⁎⁎ 96±1
GroPIns w/o 0.06±0.03 0
GroPIns4P EGTA 0.94±0.13⁎⁎⁎ 81±6
GroPIns4P U-73122 0.05±0.01 0
PDGF U-73122 0.08±0.06 0
ATP U-73122 0.07±0.10 0
GroPIns4P U-73443 1.1±0.3 56±6
GroPIns4P Genistein 0.29±0.06 22±16
PDGF Genistein 0.19±4 5±3
ATP Genistein 1.16±0.23⁎⁎⁎ 78±5
GroPIns4P SU6656/PP2 0.03±4 0
PDGF SU6656/PP2 0.08±4 0
ATP SU6656/PP2 0.75±0.3⁎⁎⁎ 90±5
Cells were selected at random and scanned for at least 30 s to establish base-line
ﬂuorescence and to check for spontaneous [Ca2+]i rises, then movies were taken over
8 min following the addition of the reported stimuli. For image analysis, the
ﬂuorescence of each frame was calculated by the TILL Photonics imaging system. The
stimulation of [Ca2+]i by 50 μMGroPIns4P, 10 ng/ml PDGF, 100 μM ATP, 10 μM ionomycin
or 100 μMGroPIns was calculated as changes in ﬂuorescence relative to base-line, as the
pseudo-ratio: ΔF/F0=(F–F0) / (F0–B) where F is the maximal level of ﬂuorescence
obtained upon stimulation, F0 is the ﬂuorescence under basal conditions, and B is the
background [41,71,72]. Apart from changes that approach dye saturation, ΔF/F0
approximately reﬂects [Ca2+]i, assuming no changes in dye concentration,
intracellular environment or path length [41,71,72]. The effects of 1 mM EGTA and of
pretreatments with the inhibitors 5 μM U-73122 (PLC inhibitor; 10 min), 5 μM U-73443
(inactive analogue of PLC inhibitor; 10 min), 10 μM genistein (tyrosine-kinase inhibitor;
30 min), 10 μM SU6656 (Src inhibitor; 10 min) and 10 μM PP2 (Src inhibitor; 10 min)
were tested. The number of responsive cells is given as the percentage of the total cells
analyzed per sample. The data are means (±s.e.) of at least 12 independent experiments
for GroPIns4P stimulation, and of at least 5 independent experiments for the other
stimuli. w/o, without.
Statistical signiﬁcance: ⁎⁎⁎Pb0.001, compared to the untreated sample (paired
Student's t test). w/o, no pretreatment.(Table 2). To determine whether the opening of calcium channels in
the plasma membrane contributed to these increases in [Ca2+]i,
control experiments were performed in a Ca2+-free buffer (containing
1 mM EGTA) [41,54]. Under these conditions, GroPIns4P addition still
resulted in an increase in [Ca2+]i that was similar to that induced in the
presence of extracellular Ca2+, thus excluding a contribution of Ca2+
inﬂux in this GroPIns4P-stimulated response (Table 2). The contribu-
tion of phospholipase C (PLC) to this increase in [Ca2+]i induced by
GroPIns4Pwas then analyzed using the speciﬁc PLC inhibitor U-73122
(5 μM) [55]. U-73122 completely inhibited the GroPIns4P-dependent
[Ca2+]i increase, whereas the inactive analogue U-73443 (5 μM) did
not (Table 2).
Altogether, these data support a role for PLC in the release of
Ca2+ from intracellular stores driven by GroPIns4P, and indicate that
this [Ca2+]i increase should originate from PLC-mediated inositol
1,4,5-trisphosphate (InsP3) formation. We thus directly evaluated
InsP3 production in NIH3T3 cells stimulated with both GroPIns4P
(50 μM) and PDGF (10 ng/ml) (see Materials and methods). In intact
cells, GroPIns4P-induced a 22% increase in InsP3 within 2 min, similar
to the effect of PDGF (37% increase) (Table 3).
We also analyzed the effects of the PLC inhibitor U-73122 [55] on
GroPIns4P-induced rufﬂe formation. In serum-starved NIH3T3 cells,
pretreated with 5 μM U-73122, GroPIns4P- and PDGF-dependent
rufﬂe formation was inhibited by about 60% and 50%, respectively
(Table 1). Again, the inactive U-73122 analogue (5 μM U-73343) was
used in parallel as a control, and it did not prevent stimulation of rufﬂe
formation by either GroPIns4P or PDGF, conﬁrming the involvement of
PLC in this process (Table 1).
Finally, we investigated which PLC isoform is involved in the
GroPIns4P-dependent InsP3 increase by selectively blocking PLCβ and
PLCγ with speciﬁc antibodies (see Materials and methods) [42].
NIH3T3 cell homogenates were incubated with GroPIns4P for 15 min
in the absence and presence of 20 μg/ml anti-PLCβ or anti-PLCγ
antibodies [42]; the GroPIns4P stimulation of InsP3 production was
prevented by the anti-PLCγ antibody and partially reduced (by about
20%) by the anti-PLCβ antibody (Table 3). The selectivity of these
antibodies was validated by stimulating cell homogenates with
thrombin (5 I.U./ml), which, as expected, produced about a 175%
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the speciﬁc PLC isoform coupled to the proteinase-activated receptor
(PAR) family, but not by the anti-PLCγ antibody (Table 3) [56,57].
These data are consistent with GroPIns4P activating PLCγ, possibly via
tyrosine-kinase-dependent phosphorylation. Indeed, an increase in
tyrosine phosphorylation was detected on immunoprecipitated PLCγ
upon addition of 50 μM GroPIns4P (as revealed by an antipho-
sphotyrosine antibody; see Materials and methods; data not shown).
In addition, a 30 min treatment with the general tyrosine-kinase
inhibitor genistein [58] greatly reduced the GroPIns4P-induced
increase in [Ca2+]i (Table 2).
In summary, the action of GroPIns4P on membrane rufﬂe
formation is mediated by tyrosine-kinase-dependent phosphorylation
that acts through PLCγ and [Ca2+]i modulation.
3.5. GroPIns4P activates Src
PLCγ is a known substrate of the Src-family kinases [59,60]. Using
the experimental approaches described above, speciﬁc inhibitors were
used to verify whether these are the kinases speciﬁcally activated by
GroPIns4P, and that lead to the phosphorylation and activation of
PLCγ. Indeed, the Src-family kinase inhibitors SU6656 and PP2 (10 μM
each) [61] completely prevented the [Ca2+]i increase (Table 2) and
reduced the formation of membrane rufﬂes induced by GroPIns4P in
NIH3T3 cells (by 80% and 70%, respectively; Table 1).
The possibility that this GroPIns4P treatment of intact NIH3T3
cells induced the activation of Src kinases was then analyzed by
Western blotting, using a speciﬁc antibody against the phosphory-
lated tyrosine 416 of Src (the site of Src autophosphorylation upon
activation) [62,63] to reveal the levels of active Src (p-Src) present in
this system (see Materials and methods). Upon treatment with
GroPIns4P, there was an 80% increase in p-Src levels; this increase
was rapid (15 s) and persisted for at least 2 min (Fig. 7A and B).
Among the different Src isoforms, the 60-kDa band corresponding to
c-Src (indicated throughout as Src) was the one modulated by
GroPIns4P (Fig. 7B).
To determine whether this GroPIns4P-dependent activation of Src
was due to the direct binding of GroPIns4P to Src itself, in-vitro SrcFig. 7. GroPIns4P-dependent Src activation. Serum-starved NIH3T3 cells were
stimulated with 50 μM GroPIns4P and/or 10 ng/ml PDGF for the indicated times. The
cells were lysed and the amounts of active Src (p-Src, tyrosine-416-phosphorylated)
were analysed by Western blotting and normalised for the total amount of c-Src in the
lysates (see Materials and methods). (A) Quantiﬁcation of Src phosphorylation, as in-
dicated. Data are expressed as percentages of the unstimulated control, as means (±s.d.)
of four independent experiments, each in duplicate. (B) Western blotting of a
representative time course of GroPIns4P-induced Src activation. Upper panel, phos-
phorylated Src (p-Src); lower panel, total Src. Statistical signiﬁcance: ⁎P<0.05, ⁎⁎P<0.01,
compared to the untreated time 0 controls (paired Student's t test). MW, molecular-
weight marker (kDa).kinase assays were performed with puriﬁed Src (see Materials and
methods). Neither GroPIns4P per se nor GroPIns4P in combination
with cell lysates (used as a supply of potential cofactors) activated Src.
These data are consistent with the hypothesis that GroPIns4P activates
Src (leading to rufﬂe formation) only in intact cells, and not in isolated
systems. PMA (10 μM) applied as a positive control induced an
expected activation of Src in the presence of cell lysate (about a 32%
increase in the basal activity of Src, which was 0.64 ±0.02 pmoles
phosphorylated peptide/minute).
To further investigate the involvement of Src kinases in GroPIns4P-
dependent rufﬂe formation, we used SYF cells, which are widely used
embryonic ﬁbroblasts that do not express the three ubiquitously
expressed Src isoforms: Src, Fyn and Yes [64]. First, the induction of
membrane rufﬂes by GroPIns4P was analyzed following the protocols
described above (see also Materials and methods). GroPIns4P did not
induce rufﬂe formation in SYF cells, whereas PDGF and PMA, applied
as controls, did (Fig. 8A and B). Importantly, after transfecting Src in
SYF cells (see Materials and methods), the GroPIns4P effect was
completely rescued, and produced a level 2.5-fold the control rufﬂe
formation, clearly indicating that Src expression was sufﬁcient to
rescue the GroPIns4P action (Fig. 8C and D). The PDGF-induced rufﬂe
formation in both wild-type SYF cells and after Src overexpression
indicates that PDGF signalling in these SYF cells diverges from that of
GroPIns4P.
In conclusion, the tyrosine-kinase Src is essential for GroPIns4P-
induced membrane rufﬂing, both in NIH3T3 and SYF ﬁbroblasts.
4. Discussion
In the present study, we delineate a novel signalling mechanism
that is initiated by the phosphoinositide metabolite GroPIns4P and
that leads to actin cytoskeleton reorganization in ﬁbroblasts.
We show that in NIH3T3 cells GroPIns4P induces rufﬂe formation
through a phosphorylation cascade involving Src, which phosphor-
ylates and hence activates PLCγ [60,65]. This results in a [Ca2+]i
increase that triggers the activation of CaMKII, which can phosphor-
ylate TIAM1 [48]. Once phosphorylated, TIAM1 translocates to the
plasma membrane and binds Rac1, thus promoting rufﬂe formation
(as schematized in Fig. 9).
Our data clearly demonstrate that the Src/Ca2+/CaMKII pathway
is essential for GroPIns4P-induced rufﬂe formation in NIH3T3 cells.
The inhibition of both PLCs and Src kinases prevented the increase
in [Ca2+]i and consequently reduced rufﬂe formation; in addition,
this GroPIns4P effect was completely inhibited in SYF cells that do
not express Src.
An open question arising from these data concerns the mechan-
isms by which GroPIns4P activates Src. Src kinases are regulated by
phosphorylation/de-phosphorylation events: Src kinase activation
arises from the autophosphorylation of tyrosine 416, whereas
phosphorylation of tyrosine 527 by the C-terminal Src kinase (CSK)
blocks its activity [62]. Protein-tyrosine phosphatases, such as PTPα,
Shp1 and Shp2, among others, remove the inhibitory phosphate (on
tyrosine 527) and activate Src kinases [63]. Since we did not see any
direct effect of GroPIns4P on Src, the possibility is that GroPIns4P
either modulates Src kinase by interacting with one of its cofactors, or
activates one of these speciﬁc Src phosphatases.
Besides the signalling cascade reported here, phosphorylated
Src could also activate other effectors that are involved in rufﬂe
formation. Vav, another speciﬁc exchange factor for Rac1, is a case
in point, since it is ubiquitously expressed and its activation
induces rufﬂe formation in ﬁbroblasts [60,66]. Vav, however, is not
activated upon GroPIns4P stimulation in NIH3T3 cells. This is at
variance with Jurkat T-cells, where GroPIns4P induces Vav
activation as a consequence of the inhibition of the adenylyl
cyclase activity induced by GroPIns4P, which results in the
activation of Lck (a member of the Src family) and, consequently
Fig. 8. GroPIns4P-dependent rufﬂe formation in SYF cells. Serum-starved SYF cells were stimulated with 50 μM GroPIns4P, 10 ng/ml PDGF or 10 μM PMA for the indicated times (see
Materials and methods). Fixed cells were stained with TRITC-labelled phalloidin and analyzed by confocal microscopy. (A) Quantiﬁcation of rufﬂe formation, as indicated (see
Materials and methods). Data are expressed as percentages of the unstimulated ZT control, as means (±s.d.) of three independent experiments, each in duplicate. (B) Representative
confocal images of actin staining, as indicated. Scale bar, 10 μm. (C) Quantiﬁcation of rufﬂe formation in SYF cells overexpressing (overex.) Src and treated as indicated (see Materials
and methods). Data are expressed as percentages of unstimulated ZT control, as means (±s.d.) of two independent experiments, each in duplicate. (D) Representative confocal images
in cells overexpressing Src (green) showing actin staining (red), as indicated. Scale bars: 10 μm. Statistical signiﬁcance: ⁎⁎P<0.01 ⁎⁎⁎P<0.001 compared to the untreated ZT controls
(paired Student's t test).
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involve adenylyl cyclase modulation: GroPIns4P-induced inhibition
of the adenylyl cyclase in these cells was prevented by pertussis
toxin treatment, a condition that did not affect GroPIns4P-induced
rufﬂe formation, thus dissociating the Gi-protein/cAMP modulation
from TIAM1 activation (Beatrice Maria Filippi, unpublished data). In
conclusion, while the GroPIns4P-induced activation of both TIAM1
and Vav involves Src kinases, the mechanisms modulating the
activity of these enzymes remain to be deﬁned.Another potential mechanism of action of GroPIns4P would
involve its binding to speciﬁc membrane receptors. No experimental
evidence has been obtained so far to support this hypothesis, despite a
number of binding experiments performed using total membranes,
plasma membranes, and intact and permeabilized cells (Beatrice
Maria Filippi, unpublished data). GroPIns4P has instead been shown to
permeate the cell membrane [68].
Our studies demonstrate that GroPIns4P is a multifunctional
compound that can modulate different cell functions. While the
Fig. 9. Schematic representation of the pathway activated by GroPIns4P that leads to the
induction of rufﬂe formation in NIH3T3 cells. GroPIns4P activates Src kinase, which
phosphorylates and activates PLCγ, leading to the consequent InsP3 production and
[Ca2+]i increase. This results in activation of CaMKII, which phosphorylates TIAM1,
facilitating its translocation to the plasma membrane and enhancing its exchange
activity versus Rac1. Once activated at the level of the plasma membrane, Rac1 pro-
motes the formation of membrane rufﬂes. GDI indicates a generic Rac1 GDP dissocia-
tion inhibitor. See text for details.
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exogenously administered GroPIns4P, it should be stressed that the
glycerophosphoinositols are present in virtually all cells [10] and that
their intracellular levels can be increased by hormone stimulation via
PLA2 IVα activation [8]. This is the case also in ﬁbroblasts, where
GroPIns4P is formed upon growth-factor stimulation [7,67]. The basal
physiological intracellular concentrations of GroPIns are in the low
micromomolar range (about 50–450 μM), with GroPIns4P and
glycerophosphoinositol 4,5-bisphosphate concentrations some 10-
fold and 100-fold lower, respectively [10]; these are concentrations
that are fully compatible with the effects studied by exogenous
administration. In addition, the glycerophosphoinositols can permeate
the plasma membrane, with kinetics compatible with the effects
exerted when they are exogenously added to cultured cells [69].
Finally, by similar mechanisms, the glycerophosphoinositols can be
released by cells that produce them at supra-physiological concentra-
tions, and can act onproximal cell systems [13,68,69]. Altogether, these
observations delineate a potential paracrine mechanism that in the
case of GroPIns4P could be exertedby its hormone-induced release (for
example, from leukocytes) [7], thus acting on target cells/tissues
(ﬁbroblasts in this case) under physiological conditions. More
speciﬁcally, the recently reported GroPIns4P modulation of the
chemotactic response in Jurkat T-cells and in peripheral blood
lymphocytes may represent an example of its paracrine activity [13].Thus, under physiological conditions an extracellular gradient arising
from the GroPIns4P that is formed and released by macrophages in
response to inﬂammatory stimuli and infection could activate T-cells,
mediating the immune response in thisway [13,70]. This potential role
of the glycerophosphoinositols is presently under investigation.
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